Skip to content

Cetera Advisor Networks LLC: NYMXF position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Cetera Advisor Networks LLC on NYMXF, newest first. How the timeline and the estimate are built.

Cetera Advisor Networks LLC held 0 NYMXF shares at 2023-09-30 per its 13F-HR filed 2023-11-14.

the latest 13F is the newest step

  1. period ended2023-09-30
    13F 0 shares
    Change vs previous 13F -118,900 shares

    13F-HR 0001085146-23-004413 filed by Cetera Advisor Networks LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2023-06-30
    13F 118,900 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $22,591.

    13F-HR 0001085146-23-003192 filed by Cetera Advisor Networks LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2023-03-31
    13F 118,900 shares
    Change vs previous 13F +51,775 shares

    <0.01% of the 13F portfolio, value $40,426.

    13F-HR 0001085146-23-002332 filed by Cetera Advisor Networks LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2022-12-31
    13F 67,125 shares
    Change vs previous 13F +50,000 shares

    <0.01% of the 13F portfolio, value $21,702.

    13F-HR 0001085146-23-001272 filed by Cetera Advisor Networks LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2022-09-30
    13F 17,125 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $7,000.

    13F-HR 0001085146-22-003931 filed by Cetera Advisor Networks LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).